FY25 Vaccines for Children
ID: 75D30125R00065Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/f79fa6f1ec60479f881a05c40d8dd555/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking manufacturers of pediatric vaccines to participate in the FY25 Vaccines for Children (VFC) program through an Indefinite Delivery Indefinite Quantity (IDIQ) contract. This procurement aims to ensure the availability of standard commercial pediatric vaccines for eligible children, enhancing public health initiatives by providing vaccines at prices below those in the commercial marketplace. The VFC program is crucial for immunizing children who are Medicaid-eligible, uninsured, or underinsured, thereby supporting effective immunization practices and improving overall vaccination coverage. Interested manufacturers should contact James Sprigler at zbs6@cdc.gov or 404.498.3879 for further details, as the solicitation outlines specific requirements for compliance with FDA regulations and operational protocols for vaccine orders.

    Point(s) of Contact
    James Sprigler
    (404) 498-3879
    zbs6@cdc.gov
    David Dombeck
    (470) 488-2695
    vwj8@cdc.gov
    Files
    Title
    Posted
    A19 Authorized Distributor of Record (ADR) Agreement.docx
    The Authorized Distributor of Record (ADR) Agreement formalizes the relationship between the Centers for Disease Control and Prevention (CDC) and a specified Manufacturer/Supplier. This contract designates CDC as the ADR in accordance with the Prescription Drug Marketing Act (PDMA) of 1988 and relevant federal regulations. The agreement obligates the CDC to comply with state and federal laws, and it requires the Manufacturer/Supplier to provide a list of authorized products for distribution or confirm the entire product line. The ADR status is maintained until one party provides a written termination notice 90 days in advance. Notably, this agreement does not alter any prior distribution contracts nor confers additional rights to the CDC beyond distribution authority. The document consists of specific sections detailing the agreement, party signatures, and an attachment listing products with their corresponding National Drug Code (NDC) numbers. This agreement underscores the regulatory framework guiding the distribution of pharmaceuticals and vaccines, ensuring compliance and transparency in federal health initiatives.
    A19 Solicitation - 75D30125R00065.pdf
    The document outlines a solicitation by the Centers for Disease Control and Prevention (CDC) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract, primarily for the procurement of pediatric vaccines under the Vaccines for Children (VFC) program. The contract aims to ensure sufficient and financially accessible vaccine supplies for eligible children, enhancing public health initiatives. Key details include the characteristics of eligible bidders, delivery expectations, and operational protocols for vaccine orders. The contractor must maintain compliance with FDA regulations, ensure proper packaging and transportation standards, and report sales data monthly. Additionally, the contract stipulates payment procedures, including electronic funds transfer, and mandates adherence to relevant federal procurement regulations designed to protect certain groups, including small businesses. This initiative underscores the federal government’s commitment to immunization and public health, establishing a structured framework to facilitate effective vaccine distribution and access for targeted populations.
    A19 Vaccine Order Limitation Chart.docx
    The document outlines a federal request for proposals (RFP) concerning the procurement of various pediatric vaccines, detailing specifications for supply and delivery. A total of 25 different vaccines are listed, including their respective minimum and maximum quantity requirements, federal excise taxes, and shelf-life stipulations of a minimum of 12 months. Each vaccine requires a minimum order of 100 doses, with maximum quantities reaching as high as 9 million doses for certain vaccines like the Human Papillomavirus and Pneumococcal Conjugate vaccines. Specific taxes range from $0.75 to $4.50 per dose, applicable to a selection of vaccines. The delivery locations and timing are yet to be determined, as indicated in the document. This RFP serves to guide vaccine manufacturers and suppliers in responding to the government’s needs for pediatric vaccination supply, ensuring public health initiatives are adequately supported through organized procurement and distribution efforts.
    Lifecycle
    Title
    Type
    FY25 Vaccines for Children
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Clinical Studies of Infectious Agents, Vaccines and Antivirals in Adult and Pediatric Human Subjects
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID), is seeking small business contractors to conduct clinical studies focused on infectious agents, vaccines, and antivirals for both adult and pediatric populations. The primary objectives include evaluating the safety, immunogenicity, and efficacy of vaccines against various viruses, including emerging threats like Zika, with a project duration anticipated from August 2026 to August 2033 under a cost-reimbursement IDIQ contract structure. This initiative builds on decades of NIH-led research and aims to advance medical research through strategic partnerships with capable small businesses. Interested parties should submit their capability statements, including prior experience and qualifications, to the primary contact, Uju Obii-Obioha, at uju.obii-obioha@nih.gov, by the specified deadlines.
    CIVICs Data Management and Coordinating Center (DMCC)
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide services for the renewal of the CIVICs Data Management and Coordinating Center (DMCC). The DMCC will support the CIVICs program by managing data, conducting analyses, and facilitating communication and coordination among various stakeholders, with a focus on advancing influenza vaccine research and development. This initiative is critical for enhancing the immunogenicity and durability of seasonal influenza vaccines and involves the operation of a scalable data management system, maintenance of public and private portals, and comprehensive program coordination. Interested parties must submit their tailored Capability Statements by 3:00 PM (Eastern Time) on January 23, 2025, to Maribel Miranda at maribel.miranda@nih.gov, with the anticipated contract award date around July 2026.
    Serological Assays for the Detection and Characterization of Influenza Viruses
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is soliciting proposals for a contract focused on serological assays for the detection and characterization of influenza viruses. The primary objectives include performing hemagglutination inhibition assays on human serum samples and developing new serology platforms that are comparable to existing methods. This initiative is crucial for enhancing influenza surveillance and vaccine effectiveness studies, addressing ongoing public health challenges. Interested parties must submit a Letter of Interest by 2:00 PM EST on February 7, 2025, and can contact Jennifer Gartzke at jgartzke@cdc.gov or 404-498-0020 for further information.
    A--Data Coordinating Center (DCC) for the Best Pharmaceuticals for Children Act (B
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and its National Institute of Child Health and Human Development (NICHD), is seeking qualified small businesses to support the Data Coordinating Center (DCC) for the Best Pharmaceuticals for Children Act (BPCA). The primary objective of this procurement is to provide comprehensive data management, analysis, and regulatory reporting services for pediatric clinical trials, ensuring compliance with FDA regulations and facilitating data submission to the FDA and the NICHD Data Repository. This initiative is crucial for enhancing pediatric health outcomes by addressing therapeutic gaps and conducting necessary clinical studies, as mandated by the reauthorized BPCA. Interested parties must submit their capability statements by January 28, 2025, and can contact Deborah Brock at Deborah.Brock@nih.gov for further information.
    CDC DFWED NARST Sensititre Supplies
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
    Maintenance for BD Flow Cytometers
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking qualified vendors to provide maintenance services for BD Flow Cytometers, including the FACSymphony A5 and FACSLyric 2, for a one-year period. The maintenance services are to be performed from February 1, 2025, to January 31, 2026, and vendors must submit quotes detailing quarterly service amounts while adhering to federal acquisition regulations. This procurement is critical for ensuring the operational efficiency of laboratory equipment used in disease control and prevention efforts. Interested vendors should contact Timothy Joyce at xvf7@cdc.gov for further details, and must be registered in the System for Award Management to be eligible for award consideration.
    CDC WORLD TRADE CENTER (WTC) HEALTH PROGRAM PHARMACY BENEFITS MANAGER
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking qualified vendors to provide Pharmacy Benefits Manager (PBM) services for the World Trade Center (WTC) Health Program, which supports responders and survivors affected by the 9/11 attacks. The procurement aims to operationalize a three-year contract that includes a 12-month implementation period, a peak operational phase, and a transition-out period, all while ensuring compliance with federal regulations and managing pharmacy benefits for a limited healthcare program. The PBM will be responsible for developing a pharmacy network, implementing electronic claims processing systems, conducting audits, and maintaining transparent pricing, among other tasks, to ensure optimal care for enrollees. Interested parties must submit their qualifications by February 14, 2025, and can direct inquiries to Laurie Presley at xnp0@cdc.gov.
    Notice of Intent to Sole Source – Meso Scale Discovery (MSD) Lab Equipment Maintenance Service Contract
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), intends to issue a sole source contract for maintenance services of Meso Scale Discovery (MSD) lab equipment. The primary objective is to ensure the proper functioning and maintenance of specialized laboratory instruments used in HIV prevention research, which includes preventive maintenance and emergency repair services. This contract is critical for supporting the CDC's Division of HIV Prevention in conducting vital scientific studies related to HIV transmission and detection. Interested vendors must respond to the notice by January 19, 2025, and direct inquiries to Stephanie Reid at qsi5@cdc.gov, as the procurement will be conducted under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1).
    World Trade Center Health Program - Outreach and Education
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), is seeking qualified vendors to provide outreach and education services for the World Trade Center (WTC) Health Program. The primary objective is to enhance awareness and participation among underrepresented populations affected by the September 11 attacks, particularly focusing on non-English speakers and low-income survivors. This initiative is crucial for ensuring that eligible individuals receive necessary medical treatment and monitoring, as current enrollment is significantly low compared to the estimated number of impacted individuals. Interested parties must submit their capability statements by February 3, 2025, and can direct inquiries to Joseph Jones at zjb2@cdc.gov. The contract is expected to run from June 1, 2025, to May 31, 2030, with a strong emphasis on culturally sensitive engagement and measurable outreach success.
    Pre-Solicitation FY 2025 CDC OS Emerging Public Health Priorities BAA
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is preparing to issue a Fiscal Year 2025 Broad Agency Announcement (BAA) for Applied Research aimed at addressing Emerging Public Health Priorities. This initiative seeks innovative research proposals in various areas, including infectious disease surveillance, wastewater surveillance, and substance use disorder recovery, to enhance public health strategies and responses to emerging threats. The BAA will be open for full and open competition, with a tentative issuance date of December 30, 2024, and a due date for concept papers set for January 30, 2025. Interested contractors must ensure they are registered in the System for Award Management (SAM) to be eligible for award, and further details will be available on SAM.gov.